Cargando…

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

To investigate the expression of programmed death-ligand 1 (PD-L1) and immune checkpoints and their prognostic value for resected head and neck squamous cell cancer (HNSCC). PD-L1 expression on tumor cells (TC) and tumor-infiltrating immune cells (IC), abundance of tumor-infiltrating lymphocytes (TI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hye Ryun, Ha, Sang-Jun, Hong, Min Hee, Heo, Su Jin, Koh, Yoon Woo, Choi, Eun Chang, Kim, Eun Kyung, Pyo, Kyoung Ho, Jung, Inkyung, Seo, Daekwan, Choi, Jaewoo, Cho, Byoung Chul, Yoon, Sun Och
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107906/ https://www.ncbi.nlm.nih.gov/pubmed/27841362 http://dx.doi.org/10.1038/srep36956

Ejemplares similares

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
por: Cho, Yoon Ah, et al.
Publicado: (2016)

NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2019)

Author Correction: NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2020)

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
por: Kang, Han Na, et al.
Publicado: (2020)

Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck
por: Choi, Seo Hee, et al.
Publicado: (2022)

Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2020)

Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
por: Youn, Je-In, et al.
Publicado: (2020)

Mouse–human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
por: Kim, Hye Ryun, et al.
Publicado: (2020)

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
por: Ahn, Beung-Chul, et al.
Publicado: (2019)

Clinical Utility of Bone Marrow Study in Gaucher Disease: A Case Report of Gaucher Disease Type 3 With Intractable Myoclonic Seizures
por: Rim, John Hoon, et al.
Publicado: (2016)

Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection
por: Cho, Yoon Ah, et al.
Publicado: (2019)

Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
por: Kim, Min Hwan, et al.
Publicado: (2020)

Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
por: Kim, Min Hwan, et al.
Publicado: (2020)

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
por: Lee, Ji Hyun, et al.
Publicado: (2021)

Selective Neck Dissection for Clinically Node-Positive Oral Cavity Squamous Cell Carcinoma
por: Shin, Yoo Seob, et al.
Publicado: (2013)

Disproportional enrichment of FoxP3(+)CD4(+) regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma
por: Park, Seyeon, et al.
Publicado: (2022)

Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital
por: Jung, JaeWoo, et al.
Publicado: (2014)

Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma
por: Cha, Yoon Jin, et al.
Publicado: (2023)

Proangiogenic cells enhanced persistent and physiologic neovascularization compared with macrophages
por: Choi, Young-Eun, et al.
Publicado: (2015)

Comprehensive Analysis of Clinicopathologic Factors Predictive of an Unfavorable Prognosis in Patients With Acinic Cell Carcinoma of the Parotid Gland
por: Park, Young Min, et al.
Publicado: (2021)

Primary Gastrointestinal T/NK Cell Lymphoma
por: Kim, Eun Kyung, et al.
Publicado: (2021)

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
por: Lim, Sun Min, et al.
Publicado: (2019)

Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma
por: Kang, Hyundeok, et al.
Publicado: (2022)

Proposal of an Appropriate Decalcification Method of Bone Marrow Biopsy Specimens in the Era of Expanding Genetic Molecular Study
por: Choi, Sung-Eun, et al.
Publicado: (2015)

Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis
por: Hong, Kyung Taek, et al.
Publicado: (2022)

Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma
por: Chang, Hyun, et al.
Publicado: (2020)

Granzyme B for predicting the durable clinical benefit of anti-PD-1/PD-L1 immunotherapy in patients with non-small cell lung cancer
por: Chung, Jae Heun, et al.
Publicado: (2022)

Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
por: Cho, Jae-Won, et al.
Publicado: (2020)

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
por: Yoo, Shin Hye, et al.
Publicado: (2019)

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2020)

Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
por: Hong, Min Hee, et al.
Publicado: (2019)

Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization
por: Kim, Hye Ryun, et al.
Publicado: (2017)

Characteristic gene alterations in primary gastrointestinal T- and NK-cell lymphomas
por: Lee, Gunho, et al.
Publicado: (2019)

Maintenance of genome integrity and active homologous recombination in embryonic stem cells
por: Choi, Eui-Hwan, et al.
Publicado: (2020)

Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2023)

Quality of cord blood cryopreserved for up to 5 years
por: Lee, Hye Ryun, et al.
Publicado: (2014)

TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
por: Park, Miso, et al.
Publicado: (2023)

High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma
por: Hong, Min Hee, et al.
Publicado: (2019)

Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas
por: Kim, Eun Kyung, et al.
Publicado: (2016)

Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study
por: Ahn, Beung-Chul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7am0plo92urr1a5k6r23u28nir